AA
AlphaCentric Advisors’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-65,500
| Closed | -$618K | – | 255 |
|
|
2021
Q3 | $618K | Buy |
65,500
+20,000
| +44% | +$189K | 0.16% | 57 |
|
|
2021
Q2 | $618K | Buy |
45,500
+15,000
| +49% | +$204K | 0.17% | 52 |
|
|
2021
Q1 | $493K | Buy |
30,500
+25,900
| +563% | +$419K | 0.17% | 47 |
|
|
2020
Q4 | $122K | Buy |
4,600
+1,750
| +61% | +$46.4K | 0.05% | 102 |
|
|
2020
Q3 | $53K | Buy |
+2,850
| New | +$53K | 0.03% | 100 |
|